au.\*:("GEORGIADIS, Dimitris")
Results 1 to 6 of 6
Selection :
Specific targeting of metzincin family members with small-molecule inhibitors: Progress toward a multifarious challengeGEORGIADIS, Dimitris; YIOTAKIS, Athanasios.Bioorganic & medicinal chemistry. 2008, Vol 16, Num 19, pp 8781-8794, issn 0968-0896, 14 p.Article
A versatile annulation protocol toward novel constrained phosphinic peptidomimeticsNASOPOULOU, Magdalini; GEORGIADIS, Dimitris; MATZIARI, Magdalini et al.Journal of organic chemistry. 2007, Vol 72, Num 19, pp 7222-7228, issn 0022-3263, 7 p.Article
Selective angiotensin-converting enzyme C-domain inhibition is sufficient to prevent angiotensin I-induced vasoconstrictionVAN ESCH, Joep H. M; TOM, Beril; DIVE, Vincent et al.Hypertension (Dallas, Tex. 1979). 2005, Vol 45, Num 1, pp 120-125, issn 0194-911X, 6 p.Article
Practical Use of Glycerol in Protein CrystallizationVERA, Laura; CZARNY, Bertrand; GEORGIADIS, Dimitris et al.Crystal growth & design. 2011, Vol 11, Num 7, pp 2755-2762, issn 1528-7483, 8 p.Article
Phosphinic Tripeptides as Dual Angiotensin-Converting Enzyme C-Domain and Endothelin-Converting Enzyme-1 InhibitorsJULLIEN, Nicolas; MAKRITIS, Anastasios; GEORGIADIS, Dimitris et al.Journal of medicinal chemistry (Print). 2010, Vol 53, Num 1, pp 208-220, issn 0022-2623, 13 p.Article
Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: Insights from selective inhibitorsGEORGIADIS, Dimitris; BEAU, Fabrice; CZARNY, Bertrand et al.Circulation research. 2003, Vol 93, Num 2, pp 148-154, issn 0009-7330, 7 p.Article